P2X7 Receptors: Channels, pores and more

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 6, 2012, Pages 705-721

  Volonte C ^a   Apolloni, S ^a   Skaper, S D ^b   Burnstock, G ^c  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Antagonists; Knock out; Nervous system; Neurodegeneration; Neuroinflammation; P2X7 receptor; Pain

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 2'(3') O (4 BENZOYLBENZOYL) ADENOSINE 5' TRIPHOSPHATE; 3 [[5 (2,3 DICHLOROPHENYL) 1H TETRAZOL 1 YL]METHYL]PYRIDINE; A 740003; A 839977; ADENOSINE TRIPHOSPHATASE; AZ 1060620; AZ 11645373; AZD 9056; CE 224; CE 535; GSK 1482160; INTERLEUKIN 1BETA; NEUROTRANSMITTER; PURINERGIC P2X RECEPTOR AGONIST; PURINERGIC P2X RECEPTOR ANTAGONIST; PURINERGIC P2X7 RECEPTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN ISCHEMIA; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL PROLIFERATION; CHANNEL GATING; CYTOKINE RELEASE; DEGENERATIVE DISEASE; EPILEPSY; GENE DUPLICATION; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUNTINGTON CHOREA; INFLAMMATORY PAIN; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROBLASTOMA; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NONHUMAN; PARKINSON DISEASE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN LOCALIZATION; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM TRANSPORT;

ANIMALS; EPILEPSY; HUMANS; ION CHANNELS; MICE; NEURALGIA; NEUROBLASTOMA; NEURODEGENERATIVE DISEASES; PERMEABILITY; PURINERGIC P2X RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2X7;

EID: 84869045095     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712803581137     Document Type: Review

References (213)

1. Trams, G.E. On the evolution of neurochemical transmission. Models and hypothesis. Heidelberg: Springer Verlag, 1981, 1-9.
2. Burnstock, G. Purinoceptors: ontogeny and phylogeny. Drug Dev. Res., 1996, 39, 204-242.
3. Burnstock, G.; Verkhratsky, A. Evolutionary origins of the purinergic signalling system. Acta Physiol., 2009, 195, 415-447.
4. Keller, R. Tissue mast cells in immune reactions. Monogr. Allergy, 1966, 2, 1-144.
5. Cockcroft, S.; Gomperts, B.D. Activation and inhibition of calcium-dependent histamine secretion by ATP ions applied to rat mast cells. J. Physiol., 1979, 296, 229-243.
6. Rozengurt, E.; Heppel, L.A. Reciprocal control of membrane permeability of transformed cultures of mouse cell lines by external and internal ATP. J. Biol. Chem., 1979, 254, 708-714.
7. Heppel, L.A.; Weisman, G.; Friedberg, I. Permeabilization of transformed cells in culture by external ATP. J. Membr. Biol., 1985, 86, 189-196.
8. Gordon, J.L. Extracellular ATP: effects, sources and fate. Biochem. J., 1986, 233(2), 309-319.
9. Di Virgilio, F.; Bronte, V.; Collavo, D.; Zanovello, P. Responses of mouse lymphocytes to extracellular adenosine 5'-triphosphate (ATP). Lymphocytes with cytotoxic activity are resistant to the permeabilizing effects of ATP. J. Immunol., 1989, 143(6), 1955-1960.
10. el-Moatassim, C.; Dubyak, G.R. A novel pathway for the activation of phospholipase D by P2z purinergic receptors in BAC1. 2F5 macrophages. J. Biol. Chem., 1992, 267(33), 23664-23673.
11. Hickman, S.E.; Semrad, C.E.; Silverstein, S.C. P2Z purinoceptors. Ciba Found. Symp., 1996, 198, 71-83.
12. Surprenant, A.; Rassendren, F.; Kawashima, E.; North, R.A.; Buell, G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science, 1996, 272(5262), 735-738.
13. Rassendren, F.; Buell, G.N.; Virginio, C.; Collo, G.; North, R.A.; Surprenant, A. The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J. Biol. Chem., 1997, 272(9), 5482-5486.
14. Buell, G.N.; Talabot, F.; Gos, A.; Lorenz, J.; Lai, E.; Morris, M.A.; Antonarakis, S.E. Gene structure and chromosomal localization of the human P2X7 receptor. Recept. Chann., 1998, 5, 347-354.
15. Cheewatrakoolpong, B.; Gilchrest, H.; Anthes, J.C.; Greenfeder, S. Identification and characterization of splice variants of the human P2X7 ATP channel. Biochem. Biophys. Res. Commun., 2005, 332(1), 17-27.
16. Feng, Y.H.; Wang, L.; Wang, Q.; Li, X.; Zeng, R.; Gorodeski, G.I. ATP stimulates GRK-3 phosphorylation and beta-arrestin-2-dependent internalization of P2X7 receptor. Am. J. Physiol. Cell Physiol., 2005, 288(6), C1342-C1356.
17. Kim, M.; Jiang, L.H.; Wilson, H.L.; North, R.A.; Surprenant, A. Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J., 2001, 20, 6347-6358.
18. Hong, S.; Schwarz, N.; Brass, A.; Seman, M.; Haag, F.; Koch-Nolte, F.; Schilling, W.P.; Dubyak, G.R. Differential regulation of P2X7 receptor activation by extracellular nicotinamide adenine dinucleotide and ecto-ADP-ribosyltransferases in murine macrophages and T cells. J. Immunol., 2009, 183(1), 578-592.
19. Seman, M.; Adriouch, S.; Scheuplein, F.; Krebs, C.; Freese, D.; Glowacki, G.; Deterre, P.; Haag, F.; Koch-Nolte, F. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity, 2003, 19(4), 571-582.
20. Lenertz, L.Y.; Wang, Z.; Guadarrama, A.; Hill, L.M.; Gavala, M.L.; Bertics, P.J. Mutation of putative N-linked GLycosylation sites on the human nucleotide receptor P2X7 reveals a key residue important for receptor function. Biochemistry, 2010, 49, 4611-4619.
21. Wu, C.; Ma, M.H.; Brown, K.R.; Geisler, M.; Li, L.; Tzeng, E.; Jia, C.Y.; Jurisica, I.; Li, S.S. Systematic identification of SH3 domainmediated human protein-protein interactions by peptide array target screening. Proteomics, 2007, 7(11), 1775-1785.
22. Iglesias, R.; Locovei, S.; Roque, A.; Alberto, A.P.; Dahl, G.; Spray, D.C.; Scemes, E. P2X7 receptor-Pannexin1 complex: pharmacology and signaling. Am. J. Physiol. Cell Physiol., 2008, 295(3), C752-C760.
23. Morelli, A.; Chiozzi, P.; Chiesa, A.; Ferrari, D.; Sanz, J.M.; Falzoni, S.; Pinton, P.; Rizzuto, R.; Olson, M.F.; Di Virgilio, F. Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells. Mol. Biol. Cell, 2003, 14(7), 2655-2664.
24. Atkinson, L.; Milligan, C.J.; Buckley, N.J.; Deuchars, J. An ATPgated ion channel at the cell nucleus. Nature, 2002, 420, 42.
25. Rassendren, F.; Buell, G.; Newbolt, A.; North, R.A.; Surprenant, A. Identification of amino acid residues contributing to the pore of a P2X receptor. EMBO J., 1997, 16, 3446-3454.
26. Roman, S.; Cusdin, F.S.; Fonfria, E.; Goodwin, J.A.; Reeves, J.; Lappin, S.C.; Chambers, L.; Walte, D.S.; Clay, W.C.; Michel, A.D. Cloning and pharmacological characterization of the dog P2X7 receptor. Br. J. Pharmacol., 2009, 158(6), 1513-1526.
27. Zimin, A.V.; Delcher, A.L.; Florea, L.; Kelley, D.R.; Schatz, M.C.; Puiu, D.; Hanrahan, F.; Pertea, G.; Van Tassell, C.P.; Sonstegard, T.S.; Marçais, G.; Roberts, M.; Subramanian, P.; Yorke, J.A.; Salzberg, S.L. A whole-genome assembly of the domestic cow, Bos taurus. Genome Biol., 2009, 10, R42.
28. Chessell, I.P.; Simon, J.; Hibell, A.D.; Michel, A.D.; Barnard, E.A.; Humphrey, P.P. Cloning and functional characterisation of the mouse P2X7 receptor. FEBS Lett., 1998, 439(1-2), 26-30.
29. Kucenas, S.; Li, Z.; Cox, J.A.; Egan, T.M.; Voigt, M.M. Molecular characterization of the zebrafish P2X receptor subunit gene family. Neuroscience, 2003, 121(4), 935-945.
30. Paukert, M.; Hidayat, S.; Gründer, S. The P2X(7) receptor from Xenopus laevis: formation of a large pore in Xenopus oocytes. FEBS Lett., 2002, 513(2-3), 253-258.
31. Fonfria, E.; Clay, W.C.; Levy, D.S.; Goodwin, J.A.; Roman, S.; Smith, G.D.; Condreay, J.P.; Michel, A.D. Cloning and pharmacological characterization of the guinea pig P2X7 receptor orthologue. Br. J. Pharmacol., 2008, 153(3), 544-556.
32. Gu, B.J.; Zhang, W.; Worthington, R.A.; Sluyter, R.; Dao-Ung, P.; Petrou, S.; Barden, J.A.; Wiley, J.S. A glu-496 to ala polymorphism leads to loss of function of the human P2X(7) receptor. J. Biol. Chem., 2001, 276, 11135-11142.
33. Skarratt, K.K.; Fuller, S.J.; Sluyter, R.; Dao-Ung, L.P.; Gu, B.J.; Wiley, J.S. A 5' intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1-2% of the Caucasian population. FEBS Lett., 2005, 579(12), 2675-2678.
34. Adriouch, S.; Dox, C.; Welge, V.; Seman, M.; Koch-Nolte, F.; Haag, F. Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J. Immun., 2002, 169, 4108-4112.
35. Worthington, R.A.; Smart, M.L.; Gu, B.J.; Williams, D.A.; Petrou, S.; Wiley, J.S.; Barden, J.A. Point mutations confer loss of ATPinduced human P2X(7) receptor function. FEBS Lett., 2002, 512, 43-46.
36. Nicke, A.; Kuan, Y.H.; Masin, M.; Rettinger, J.; Marquez-Klaka, B.; Bender, O.; Górecki, D.C.; Murrell-Lagnado, R.D.; Soto, F. A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice. J. Biol. Chem., 2009, 284(38), 25813-25822.
37. Buell, G.; Chessell, I.P.; Michel, A.D.; Collo, G.; Salazzo, M.; Herren, S.; Gretener, D.; Grahames, C.; Kaur, R.; Kosco-Vilbois, M.H.; Humphrey, P.P. Blockade of human P2X7 receptor function with a monoclonal antibody. Blood, 1998, 92(10), 3521-3528.
38. Gartland, A.; Buckley, K.A.; Bowler, W.B.; Gallagher, J.A. Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro. Calcif. Tissue Int., 2003, 73(4), 361-369.
39. Solini, A.; Chiozzi, P.; Morelli, A.; Fellin, R.; Di Virgilio, F. Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J. Cell Sci., 1999, 112, 297-305.
40. Berchtold, S.; Ogilvie, A.L.; Bogdan, C.; Mühl-Zürbes, P.; Ogilvie, A.; Schuler, G.; Steinkasserer, A. Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases. FEBS Lett., 1999, 458(3), 424-428.
41. Sluyter, R.; Barden, J.A.; Wiley, J.S. Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res., 2001, 304(2), 231-236.
42. Sluyter, R.; Shemon, A.N.; Barden, J.A.; Wiley, J.S. Extracellular ATP increases cation fluxes in human erythrocytes by activation of the P2X7 receptor. J. Biol. Chem., 2004, 279(43), 44749-44755.
43. Yip, L.; Woehrle, T.; Corriden, R.; Hirsh, M.; Chen, Y.; Inoue, Y.; Ferrari, V.; Insel, P.A.; Junger, W.G. Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J., 2009, 23(6), 1685-1693.
44. Greig, A.V.; Linge, C.; Terenghi, G.; McGrouther, D.A.; Burnstock, G. Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. J. Invest. Dermatol., 2003, 120(6), 1007-1015.
45. Yiangou, Y.; Facer, P.; Durrenberger, P.; Chessell, I.P.; Naylor, A.; Bountra, C.; Banati, R.R.; Anand, P. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol., 2006, 6, 12.
46. Amadio, S.; Montilli, C.; Magliozzi, R.; Bernardi, G.; Reynolds, R.; Volonté, C. P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis. Cereb. Cortex, 2010, 20(6), 1263-1273.
47. Amadio, S.; Apolloni, S.; D'Ambrosi, N.; Volonté, C. Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis. J. Neurochem., 2011, 116(5), 796-805.
48. O'Reilly, B.A.; Kosaka, A.H.; Chang, T.K.; Ford, A.P.; Popert, R.; Rymer, J.M.; McMahon, S.B. A quantitative analysis of purinoceptor expression in human fetal and adult bladders. J. Urol., 2001, 165(5), 1730-1734.
49. Narcisse, L.; Scemes, E.; Zhao, Y.; Lee, S.C.; Brosnan, C.F. The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes. Glia, 2005, 49(2), 245-258.
50. Collo, G.; Neidhart, S.; Kawashima, E.; Kosco-Vilbois, M.; North, R.A.; Buell, G. Tissue distribution of the P2X7 receptor. Neuropharmacology, 1997, 36(9), 1277-1283.
51. Yu, Y.; Ugawa, S.; Ueda, T.; Ishida, Y.; Inoue, K.; Kyaw Nyunt, A.; Umemura, A.; Mase, M.; Yamada, K.; Shimada, S. Cellular localization of P2X7 receptor mRNA in the rat brain. Brain Res., 2008, 1194, 45-55.
52. Tenneti, L.; Gibbons, S.J.; Talamo, B.R. Expression and transsynaptic regulation of P2x4 and P2z receptors for extracellular ATP in parotid acinar cells. Effects of parasympathetic denervation. J. Biol. Chem., 1998, 273(41), 26799-26808.
53. Hodges, R.R.; Vrouvlianis, J.; Shatos, M.A.; Dartt, D.A. Characterization of P2X7 purinergic receptors and their function in rat lacrimal gland. Invest. Ophthalmol. Vis. Sci., 2009, 50(12), 5681-5689.
54. Brändle, U.; Kohler, K.; Wheeler-Schilling, T.H. Expression of the P2X7-receptor subunit in neurons of the rat retina. Brain Res. Mol. Brain Res., 1998, 62(1), 106-109.
55. Sugiyama, T.; Oku, H.; Shibata, M.; Fukuhara, M.; Yoshida, H.; Ikeda, T. Involvement of P2X7 receptors in the hypoxia-induced death of rat retinal neurons. Invest. Ophthalmol. Vis. Sci., 2010, 51(6), 3236-3243.
56. Coutinho-Silva, R.; Parsons, M.; Robson, T.; Lincoln, J.; Burnstock, G. P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats. Mol. Cell. Endocrinol., 2003, 204(1-2), 141-154.
57. Emmett, D.S.; Feranchak, A.; Kilic, G.; Puljak, L.; Miller, B.; Dolovcak, S.; McWilliams, R.; Doctor, R.B.; Fitz, J.G. Characterization of ionotrophic purinergic receptors in hepatocytes. Hepatology, 2008, 47(2), 698-705.
58. Franke, H.; Günther, A.; Grosche, J.; Schmidt, R.; Rossner, S.; Reinhardt, R.; Faber-Zuschratter, H.; Schneider, D.; Illes, P. P2X7 receptor expression after ischemia in the cerebral cortex of rats. J. Neuropathol. Exp. Neurol., 2004, 63(7), 686-699.
59. Naemsch, L.N.; Dixon, S.J.; Sims, S.M. Activity-dependent development of P2X7 current and Ca2+ entry in rabbit osteoclasts. J. Biol. Chem., 2001, 276(42), 39107-39114.
60. Cavaliere, F.; Amadio, S.; Sancesario, G.; Bernardi, G.; Volonté C. Synaptic P2X7 and oxygen/glucose deprivation in organotypic hippocampal cultures. J. Cereb. Blood Flow Metab., 2004, 24(4), 392-398.
61. Melani, A.; Amadio, S.; Gianfriddo, M.; Vannucchi, M.G.; Volontè, C.; Bernardi, G.; Pedata, F.; Sancesario, G. P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J. Cereb. Blood Flow Metab., 2006, 26(7), 974-982.
62. Frizzo, J.K.; Cardoso, M.P.; de Assis, A.M.; Perry, M.L.; Volonté, C.; Frizzo, M.E. Effects of acute perinatal asphyxia in the rat hippocampus. Cell Mol. Neurobiol., 2010, 30(5), 683-692.
63. Ferrari, D.; Chiozzi, P.; Falzoni, S.; Dal Susino, M.; Collo, G.; Buell, G.; Di Virgilio, F. ATP-mediated cytotoxicity in microglial cells. Neuropharmacology, 1997, 36(9), 1295-1330.
64. Sim, J.A.; Young, M.T.; Sung, H.Y.; North, R.A.; Surprenant, A. Reanalysis of P2X7 receptor expression in rodent brain. J. Neurosci., 2004, 24(28), 6307-6314.
65. Colomar, A.; Amédée, T. ATP stimulation of P2X(7) receptors activates three different ionic conductances on cultured mouse Schwann cells. Eur. J. Neurosci., 2001, 14(6), 927-936.
66. Hillman, K.A.; Johnson, T.M.; Winyard, P.J.; Burnstock, G.; Unwin, R.J.; Woolf, A.S. P2X(7) receptors are expressed during mouse nephrogenesis and in collecting duct cysts of the cpk/cpk mouse. Exp. Nephrol., 2002, 10(1), 34-42.
67. Ke, H.Z.; Qi, H.; Weidema, A.F.; Zhang, Q.; Panupinthu, N.; Crawford, D.T.; Grasser, W.A.; Paralkar, V.M.; Li, M.; Audoly, L.P.; Gabel, C.A.; Jee, W.S.; Dixon, S.J.; Sims, S.M.; Thompson, D.D. Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol. Endocrinol., 2003, 17(7), 1356-1367.
68. Grol, M.W.; Panupinthu, N.; Korcok, J.; Sims, S.M.; Dixon, S.J. Expression, signaling, and function of P2X7 receptors in bone. Purinergic Signal., 2009, 5(2), 205-221.
69. Bulanova, E.; Budagian, V.; Orinska, Z.; Hein, M.; Petersen, F.; Thon, L.; Adam, D.; Bulfone-Paus, S. Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells. J. Immunol., 2005, 174(7), 3880-3890.
70. D'Ambrosi, N.; Finocchi, P.; Apolloni, S.; Cozzolino, M.; Ferri, A.; Padovano, V.; Pietrini, G.; Carrì, M.T.; Volonté, C. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. J. Immunol., 2009, 183(7), 4648-4656.
71. Wiley, J.S.; Chen, J.R.; Snook, M.S.; Gargett, C.E.; Jamieson, G.P. Transduction mechanisms of P2Z purinoceptors. Ciba Found. Symp., 1996, 198, 149-160.
72. Reyes, J.P.; Pérez-Cornejo, P.; Hernández-Carballo, C.Y.; Srivastava, A.; Romanenko, V.G.; Gonzalez-Begne, M.; Melvin, J.E.; Arreola, J. Na+ modulates anion permeation and block of P2X7 receptors from mouse parotid glands. J. Membr. Biol., 2008, 223(2), 73-85.
73. Arreola, J.; Melvin, J.E. A novel chloride conductance activated by extracellular ATP in mouse parotid acinar cells. J. Physiol., 2003, 547(Pt 1), 197-208.
74. Yan, Z.; Khadra, A.; Li, S.; Tomic, M.; Sherman, A.; Stojilkovic, S.S. Experimental characterization and mathematical modeling of P2X7 receptor channel gating. J. Neurosci., 2010, 30(42), 14213-14224.
75. Donnelly-Roberts, D.L.; Namovic, M.T.; Faltynek, C.R.; Jarvis, M.F. Mitogen-activated protein kinase and caspase signaling pathways are required for P2X7 receptor(P2X7R)-induced pore formation in human THP-1 cells. J. Pharmacol. Exp. Ther., 2004, 308(3), 1053-1061.
76. Arulkumaran, N.; Unwin, R.J.; Tam, F.W. A potential therapeutic role for P2X7 receptor(P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin. Investig. Drugs, 2011, 20(7), 897-915.
77. Donnelly-Roberts, D.L.; Jarvis, M.F. Discovery of P2X7 receptorselective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Br. J. Pharmacol., 2007, 151(5), 571-579.
78. McGaraughty, S.; Chu, K.L.; Namovic, M.T.; Donnelly-Roberts, D.L.; Harris, R.R.; Zhang, X.F.; Shieh, C.C.; Wismer, C.T.; Zhu, C.Z.; Gauvin, D.M.; Fabiyi, A.C.; Honore, P.; Gregg, R.J.; Kort, M.E.; Nelson, D.W.; Carroll, W.A.; Marsh, K.; Faltynek, C.R.; Jarvis, M.F. P2X7-related modulation of pathological nociception in rats. Neuroscience, 2007, 146(4), 1817-1828.
79. Donnelly-Roberts, D.L.; Namovic, M.T.; Han, P.; Jarvis, M.F. Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br. J. Pharmacol., 2009, 157(7), 1203-1214.
80. Honore, P.; Donnelly-Roberts, D.; Namovic, M.; Zhong, C.; Wade, C.; Chandran, P.; Zhu, C.; Carroll, W.; Perez-Medrano, A.; Iwakura, Y.; Jarvis, M.F. The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1ab knockout mice. Behav. Brain Res., 2009, 204, 77-81.
81. Friedle, S.A.; Curet, M.A.; Watters, J.J. Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation. Rec. Pat. CNS Drug Discov., 2010, 5(1), 35-45.
82. Michel, A.D.; Chamber, L.J.; Walter, D.S. Negative and positive allosteric modulators of the P2X(7) receptor. Br. J. Pharmacol., 2008, 153(4), 37-50.
83. Michel, A.D.; Ng, S.W.; Roman, S.; Clay, W.C.; Dean, D.K.; Walter D.S. Mechanism of action of species-selective P2X(7) receptor antagonists. Br. J. Pharmacol., 2009, 156, 1312-1325.
84. Murgia, M.; Hanau, S.; Pizzo, P.; Rippa, M.; Di Virgilio, F. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem., 1993, 268(11), 8199-8203.
85. Chessell, I.P.; Michel, A.D.; Humphrey, P.P. Effects of antagonists at the human recombinant P2X7 receptor. Br. J. Pharmacol., 1998, 124, 1314-1320.
86. Skaper, S.D.; Facci, L.; Culbert, A.; Evans, N.A.; Chessell, I.; Davis, J.B.; Richardson, J.C. P2X7 receptors on microglial cells mediate injury to cortical neurons in vitro. Glia, 2006, 54, 234-242.
87. Gunosewoyo, H.; Coster, M.J.; Kassiou, M. Molecular probes for P2X7 receptor studies. Curr. Med. Chem., 2007, 14(14), 1505-1523.
88. Takenouchi, T.; Sekiyama, K.; Sekigawa, A.; Fujita, M.; Waragai, M.; Sugama, S.; Iwamaru, Y.; Kitani, H.; Hashimoto, M. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases. Arch. Immunol. Ther. Exp. (Warsz), 2010, 58(2), 91-96.
89. Yan, Z.; Khadra, A.; Sherman, A.; Stojilkovic, S.S. Calciumdependent block of P2X7 receptor channel function is allosteric. J. Gen. Physiol., 2011, 138(4), 437-452.
90. Liu, X.; Surprenant, A.; Mao, H.J.; Roger, S.; Xia, R.; Bradley, H.; Jiang, L.H. Identification of key residues coordinating functional inhibition of P2X7 receptors by zinc and copper. Mol. Pharmacol., 2008, 73(1), 252-259.
91. Liu, X.; Ma, W.; Surprenant, A.; Jiang, L.H. Identification of the amino acid residues in the extracellular domain of rat P2X(7) receptor involved in functional inhibition by acidic pH. Br. J. Pharmacol., 2009, 156(1), 135-142.
92. Kubick, C.; Schmalzing, G.; Markwardt, F. The effect of anions on the human P2X7 receptor. Biochim. Biophys. Acta, 2011, 1808(12), 2913-2922.
93. Zhao, Q.; Yang.M.; Ting, A.T.; Logothetis, D.E. PIP(2) regulates the ionic current of P2X receptors and P2X(7) receptor-mediated cell death. Channels (Austin), 2007, 1, 46-55.
94. Michel, A.D.; Xing, M.; Thompson, K.M.; Jones, C.A.; Humphrey, P.P. Decavanadate, a P2X receptor antagonist, and its use to study ligand interactions with P2X7 receptors. Eur. J. Pharmacol., 2006, 534(1-3), 19-29.
95. Liu, J.; Gao, X.F.; Ni, W.; Li, J.B. Effects of propofol on P2X7 receptors and the secretion of tumor necrosis factor-α in cultured astrocytes. Clin. Exp. Med., 2012, 12(1), 31-37.
96. Nörenberg, W.; Hempel, C.; Urban, N.; Sobottka, H.; Illes, P.; Schaefer, M. Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations. J. Biol. Chem., 2011, 286(13), 11067-11081.
97. Hansen Mitchell, A.; Barden Julian, A.; Balca Vladimir, J.; Keay Kevin, A.; Bennett Maxwell, R. Structural motif and characteristics of the extracellular domain of P2X receptors. BBRC, 1997, 236, 670-675.
98. Amstrup, J.; Novak, I. P2X7 receptor activates extracellular signalregulated kinases ERK1 and ERK2 independently of Ca2+ influx. Biochem. J., 2003, 374(Pt 1), 51-61.
99. Teixeira, P.C.; de Souza, C.A.; de Freitas, M.S.; Foguel, D.; Caffarena, E.R.; Alves L.A. Predictions suggesting a participation of beta-sheet configuration in the M2 domain of the P2X(7) receptor: a novel conformation? Biophys. J., 2009, 96(3), 951-963.
100. Costa-Junior, H.M.; Sarmento Vieira, F.; Coutinho-Silva, R. C terminus of the P2X7 receptor: treasure hunting. Purinergic Signal., 2011, 7(1), 7-19.
101. Kim, M.; Spelta, V.; Sim, J.; North, R.A.; Surprenant, A. Differential assembly of rat purinergic P2X7 receptor in immune cells of the brain and periphery. J. Biol. Chem., 2001, 276(26), 23262-23267.
102. Guo, C.; Masin, M.; Qureshi, O.S.; Murrell-Lagnado, R.D. Evidence for functional P2X4/P2X7 heteromeric receptors. Mol. Pharmacol., 2007, 72(6), 1447-1456.
103. Dubyak, G.R. Go it alone no more: P2X7 joins the society of heteromeric ATP-gated receptor channels. Mol. Pharmacol., 2007, 72(6), 1402-1405.
104. Casas-Pruneda, G.; Reyes, J.P.; Pérez-Flores, G.; Pérez-Cornejo, P.; Arreola, J. Functional interactions between P2X4 and P2X7 receptors from mouse salivary epithelia. J. Physiol., 2009, 587(Pt 12), 2887-2901.
105. Nicke, A. Homotrimeric complexes are the dominant assembly state of native P2X7 subunits. Biochem. Biophys. Res. Comm., 2008, 377, 803-808.
106. Wilson, H.L.; Wilson, S.A.; Surprenant, A.; North, R.A. Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus. J. Biol. Chem., 2002, 277, 34017-34023.
107. North, R.A. Molecular physiology of P2X receptors. Physiol. Rev., 2002, 82, 1013-1067.
108. Virginio, C.; MacKenzie, A.B.; North, R.A.; Surprenant, A. Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J. Physiol., 1999, 519, 335-346.
109. Pelegrin, P.; Surprenant, A. The P2X(7) receptor-pannexin connection to dye uptake and IL-1beta release. Purinergic Signal., 2009, 5, 129-137.
110. Marques-da-Silva, C.; Chaves, M.M.; Castro, N.G.; Coutinho-Silva, R.; Guimaraes, M.Z. P. Colchicine inhibits cationic dye uptake induced by ATP in P2X2-and P2X7-expressing cells: implication for its therapeutic action. Br. J. Pharmacol., 2011, 163, 912-926.
111. Pelegrin, P.; Surprenant, A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J., 2006, 25(21), 5071-5082.
112. Hanley, P.J.; Kronlage, M.; Kirschning, C.; Del Rey, A.; Di Virgilio, F.; Leipziger, J.; Chessell, I.P.; Sargin, S.; Filippov, M.A.; Lindemann, O.; Mohr, S.; Koenigs, V.; Schillers, H.; Baehle, M.; Schwab, A. Transient P2X7 receptor activation triggers macrophage death independent of TLR2/4, Casp1 and Panx1. J. Biol. Chem., 2012, 287(13), 10650-10663.
113. Gulbransen, B.D.; Bashashati, M.; Hirota, S.A.; Gui, X.; Roberts, J.A.; Macdonald, J.A.; Muruve, D.A.; McKay, D.M.; Beck, P.L.; Mawe, G.M.; Thompson, R.J.; Sharkey, K.A. Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat. Med., 2012, 18(4), 600-604.
114. Roger, S.; Gillet, L.; Baroja-Mazo, A.; Surprenant, A.; Pelegrin, P. C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation. J. Biol. Chem., 2010, 285, 17514-17524.
115. Weisman, G.A.; Camden, J.M.; Peterson, T.S.; Ajit, D.; Woods, L.T.; Erb, L. P2 Receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y(2) receptor interactions in neuroinflammation. Mol. Neurobiol., 2012.
116. Skaper, S.D.; Debetto, P.; Giusti, P. The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J., 2010, 24(2), 337-345.
117. Skaper, S.D.; Giusti, P. P2X(7) Receptors as a transducer in the cooccurrence of neurological/psychiatric and cardiovascular disorders: a hypothesis. Cardiovasc. Psychiatry Neurol., 2009, 54, 52-63.
118. Duan, S.; Neary, J.T. P2X(7) receptors: properties and relevance to CNS function. Glia, 2006, 54(7), 738-746.
119. Le Feuvre, R.; Brough, D.; Rothwell, N. Extracellular ATP and P2X7 receptors in neurodegeneration. Eur. J. Pharmacol., 2002, 447(2-3), 261-269.
120. Di Virgilio, F. The P2z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today, 1995, 16, 524-528.
121. Sperlágh, B.; Köfalvi, A.; Deuchars, J.; Atkinson, L.; Milligan, C.J.; Buckley, N.J.; Vizi, E.S. Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J. Neurochem., 2002, 81(6), 1196-1211.
122. Sugiyama, T.; Kobayashi, M.; Kawamura, H.; Li, Q.; Puro, D.G. Enhancement of P2X7-induced pore formation and apoptosis: an early effect of diabetes on the retinal microvasculature. Invest. Ophthal. Vis. Sci., 2004, 45, 1026-1032.
123. Lemaire, I.; Falzoni, S.; Leduc, N.; Zhang, B.; Pellegatti, P.; Adinolfi, E.; Chiozzi, P.; Di Virgilio, F. Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells. J. Immunol., 2006, 177, 7257-7265.
124. Raffaghello, L.; Chiozzi, P.; Falzoni, S.; Di Virgilio, F.; Pistoia, V. The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. Cancer Res., 2006, 66(2), 907-914.
125. Monif, M.; Reid, C.A.; Powell, K.L.; Smart, M.L.; William, D.A. The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J. Neurosci., 2009, 29(12), 3781-3791.
126. Ortega, F.; Pérez-Sen, R.; Delicado, E.G.; Teresa Miras-Portugal, M. ERK1/2 activation is involved in the neuroprotective action of P2Y13 and P2X7 receptors against glutamate excitotoxicity in cerebellar granule neurons. Neuropharmacology, 2011, 61(8), 210-221.
127. Thompson, B.A.; Storm, M.P.; Hewinson, J.; Hogg, S.; Welham, M.J.; MacKenzie, A.B. A novel role for P2X7 receptor signalling in the survival of mouse embryonic stem cells. Cell Signal., 2012, 24(3), 770-778.
128. Adinolfi, E.; Cirillo, M.; Woltersdorf, R.; Falzoni, S.; Chiozzi, P.; Pellegatti, P.; Callegari, M.G.; Sandonà, D.; Markwardt, F.; Schmalzing, G.; Di Virgilio, F. Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor. FASEB J., 2010, 24(9), 3393-3404.
129. Saunders, B.M.; Fernando, S.L.; Sluyter, R.; Britton, W.J.; Wiley, J.S. A loss-of-function polymorphism in the human P2X(7) receptor abolishes ATP-mediated killing of mycobacteria. J. Immun., 2003, 171, 5442-5446.
130. Fernando, S.L.; Saunders, B.M.; Sluyter, R.; Skarratt, K.K.; Goldberg, H.; Marks, G.B.; Wiley, J.S.; Britton, W.J. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. Am. J. Respir. Crit. Care Med., 2007, 175(4), 360-366.
131. Niño-Moreno, P.; Portales-Pérez, D.; Hernández-Castro, B.; Portales-Cervantes, L.; Flores-Meraz, V.; Baranda, L.; Gómez-Gómez, A.; Acuña-Alonzo, V.; Granados, J.; González-Amaro, R. P2X7 and NRAMP1/SLC11 A1 gene polymorphisms in Mexican mestizo patients with pulmonary tuberculosis. Clin. Exp. Immunol., 2007, 148(3), 469-477.
132. Dardano, A.; Falzoni, S.; Caraccio, N.; Polini, A.; Tognini, S.; Solini, A.; Berti, P.; Di Virgilio, F.; Monzani, F. 1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters. J. Clin. Endocrinol. Metab., 2009, 94(2), 695-698.
133. Cabrini, G.; Falzoni, S.; Forchap, S.L.; Pellegatti, P.; Balboni, A.; Agostini, P.; Cuneo, A.; Castoldi, G.; Baricordi, O.R.; Di Virgilio, F. A his-155 to tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J. Immun., 2005, 175, 82-89.
134. Ohlendorff, S.D.; Tofteng, C.L.; Jensen, J.E.; Petersen, S.; Civitelli, R.; Fenger, M.; Abrahamsen, B.; Hermann, A.P.; Eike, P.; Jørgensen, N.R. Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment. Pharmacogenet. Genomics, 2007, 17(7), 555-567.
135. Nissen, N.; Madsen, J.S.; Bladbjerg, E.M.; Beck Jensen, J.E.; Jørgensen, N.R.; Langdahl, B.; Abrahamsen, B.; Brixen, K. No association between hip geometry and four common polymorphisms associated with fracture: the Danish osteoporosis prevention study. Calcif. Tissue Int., 2009, 84(4), 276-285.
136. Barden, N.; Harvey, M.; Gagné, B.; Shink, E.; Tremblay, M.; Raymond, C.; Labbé, M.; Villeneuve, A.; Rochette, D.; Bordeleau, L.; Stadler, H.; Holsboer, F.; Müller-Myhsok, B. Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24. 31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet., 2006, 141B(4), 374-382.
137. Lucae, S.; Salyakina, D.; Barden, N.; Harvey, M.; Gagné, B.; Labbé, M.; Binder, E.B.; Uhr, M.; Paez-Pereda, M.; Sillaber, I.; Ising, M.; Brückl, T.; Lieb, R.; Holsboer, F.; Müller-Myhsok, B. P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated ith major depressive disorder. Hum. Mol. Genet., 2006, 15(16), 2438-2445.
138. McQuillin, A.; Bass, N.J.; Choudhury, K.; Puri, V.; Kosmin, M.; Lawrence, J.; Curtis, D.; Gurling, H.M. Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar-and unipolar-affective disorders. Mol. Psychiatry, 2009, 14(6), 614-620.
139. Oyanguren-Desez, O.; Rodríguez-Antigüedad, A.; Villoslada, P.; Domercq, M.; Alberdi, E.; Matute, C. Gain-of-function of P2X7 receptor gene variants in multiple sclerosis. Cell Calcium, 2011, 50(5), 468-472.
140. Solle, M.; Labasi, J.; Perregaux, D.G.; Stam, E.; Petrushova, N.; Koller, B.H.; Griffiths, R.J.; Gabel, C.A. Altered cytokine production in mice lacking P2X7 receptors. J. Biol. Chem., 2001, 276(1), 125-132.
141. Chessell, I.P.; Hatcher, J.P.; Bountra, C.; Michel, A.D.; Hughes, J.P.; Green, P.; Egerton, J.; Murfin, M.; Richardson, J.; Peck, W.L.; Grahames, C.B.; Casula, M.A.; Yiangou, Y.; Birch, R.; Anand, P.; Buell, G.N. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain, 2005, 114(3), 386-396.
142. Masin, M.; Young, C.; Lim, K., Barnes, S.J.; Xu, X.J.; Marschall, V.; Brutkowski, W.; Mooney, E.R.; Gorecki, D.C.; Murrell-Lagnado, R. Expression, assembly and function of novel Cterminal truncated variants of the mouse P2X7 receptor: reevaluation of P2X7 knockouts. Br. J. Pharmacol., 2012, 165(4), 978-993.
143. Labasi, J.M.; Petrushova, N.; Donovan, C.; McCurdy, S.; Lira, P.; Payette, M.M.; Brissette, W.; Wicks, J.R.; Audoly, L.; Gabel, C.A. Absence of the P2X7 receptor alters leukocytefunction and attenuates an inflammatory response. J. Immunol., 2002, 168(12), 6436-6445.
144. Papp, L.; Vizi, E.S.; Sperlágh, B. Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor-/-mice. Neuroreport, 2004, 15(15), 2387-2391.
145. Sanz, J.M.; Chiozzi, P.; Ferrari, D.; Colaianna, M.; Idzko, M.; Falzoni, S.; Fellin, R.; Trabace, L.; Di Virgilio, F. Activation of microglia by amyloid {beta} requires P2X7 receptor expression. J. Immunol., 2009, 182(7), 4378-4385.
146. Hracskó, Z.; Baranyi, M.; Csölle, C.; Gölöncsér, F.; Madarász, E.; Kittel, A.; Sperlágh, B. Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease. Mol. Neurodegener., 2011, 6, 28.
147. Weber, F.C.; Esser, P.R.; Muller, T.; Ganesan, J.; Pellegatti, P.; Simon, M.M.; Zeiser, R.; Idzko, M.; Jakob, T.; Martin, S.F. Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J. Exp. Med., 2010, 207, 2609-2619.
148. Lucattelli, M.; Cicko, S.; Müller, T.; Lommatzsch, M.; De Cunto, G.; Cardini, S.; Sundas, W.; Grimm, M.; Zeiser, R.; Dürk, T.; Zissel, G.; Sorichter, S.; Ferrari, D.; Di Virgilio, F.; Virchow, J.C.; Lungarella, G.; Idzko, M. P2X7 Receptor Signalling in the Pathogenesis of Smoke-induced Lung Inflammation and Emphysema. Am. J. Respir. Cell Mol. Biol., 2011, 44(3), 423-429.
149. Muller, T.; Paula Vieira, R.; Grimm, M.; Durk, T.; Cicko, S.; Zeiser, R.; Jakob, T.; Martin, S.F.; Blumenthal, B.; Sorichter, S.; Ferrari, D.; Di Virgillio, F.; Idzko, M. A potential role for p2x7r in allergic airway inflammation in mice and humans. Am. J. Respir. Cell Mol. Biol., 2011, 44(4), 456-464.
150. Riteau, N.; Gasse, P.; Fauconnier, L.; Gombault, A.; Couegnat, M.; Fick, L.; Kanellopoulos, J.; Quesniaux, V.F.; Marchand-Adam, S.; Crestani, B.; Ryffel, B.; Couillin, I. Extracellular ATP is a danger signal activating p2x7 receptor in lung inflammation and fibrosis. Am. J. Respir. Crit. Care Med., 2010, 182(6), 774-783.
151. Monção-Ribeiro, L.C.; Cagido, V.R.; Lima-Murad, G.; Santana, P.T.; Riva, D.R.; Borojevic, R.; Zin, W.A.; Cavalcante, M.C.; Riça, I.; Brando-Lima, A.C.; Takiy, C.M.; Faffe, D.S.; Coutinho-Silva, R. Lipopolysaccharide-induced lung injury: role of P2X7 receptor. Respir. Physiol. Neurobiol., 2011, 179(2-3), 314-325.
152. Novak, I.; Jans, I.M.; Wohlfahrt, L. Effect of P2X(7) receptor knockout on exocrine secretion of pancreas, salivary glands and lacrimal glands. J. Physiol., 2010, 588(Pt 18), 3615-3627.
153. Basso, A.M.; Bratcher, N.A.; Harris, R.R.; Jarvis, M.F.; Decker, M.W.; Rueter, L.E. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders. Behav. Brain Res., 2009, 198(1), 83-90.
154. Csölle, C.; Andó, R.D.; Kittel, A.; Gölöncsér, F.; Baranyi, M.; Soproni, K.; Zelena, D.; Haller, J.; Németh, T.; Mócsai, A.; Sperlágh, B. The absence of P2X7 receptors(P2rx7) on non haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice. Int. J. Neuropsychopharmacol., 2012, 16, 1-21.
155. Hansen, R.R.; Nielsen, C.K.; Nasser, A.; Thomsen, S.I.; Eghorn, L.F.; Pham, Y.; Schulenburg, C.; Syberg, S.; Ding, M.; Stojilkovic, S.S.; Jorgensen, N.R.; Heegaard, A.M. P2X7 receptor-deficient mice are susceptible to. Pain, 2011, 152(8), 1766-1776.
156. Taylor, S.R.; Turner, C.M.; Elliott, J.I.; McDaid, J.; Hewitt, R.; Smith, J.; Pickering, M.C.; Whitehouse, D.L.; Cook, H.T.; Burnstock, G.; Pusey, C.D.; Unwin, R.J.; Tam, F.W. P2X7 deficiency attenuates renal injury in experimental glomerulonephritis. J. Am. Soc. Nephrol., 2009, 20(3), 1275-1281.
157. Wilhelm, K.; Ganesan, J.; Müller, T.; Dürr, C.; Grimm, M.; Beilhack, A.; Krempl, C.D.; Sorichter, S.; Gerlach, U.V.; Jüttner, E.; Zerweck, A.; Gärtner, F.; Pellegatti, P.; Di Virgilio, F.; Ferrari, D.; Kambham, N.; Fisch, P.; Finke, J.; Idzko, M.; Zeiser, R. Graftversus-host disease is enhanced by extracellular ATP activating P2X7R. Nat. Med., 2010, 16(12), 1434-1438.
158. Mayo, C.; Ren, R.; Rich, C.; Stepp, M.A.; Trinkaus-Randall, V. Regulation by P2X7: epithelial migration and stromal organization in the cornea. Invest. Ophthalmol. Vis. Sci., 2008, 49(10), 4384-4391.
159. Kawamura, H.; Aswad, F.; Minagawa, M.; Govindarajan, S.; Dennert, G. P2X7 receptors regulate NKT cells in autoimmune hepatitis. J. Immunol., 2006, 176(4), 2152-2160.
160. Gonçalves, R.G.; Gabrich, L.; Rosário, A.; Takiya, C.M.; Ferreira, M.L.; Chiarini, L.B.; Persechini, P.M.; Coutinho-Silva, R.; Leite, M. The role of purinergic P2X7 receptors in the inflammation and fibrosis of unilateral ureteral obstruction in mice. Kidney Int., 2006, 70(9), 1599-1606.
161. Sharp, A.J.; Polak, P.E.; Simonini, V.; Lin, S.X.; Richardson, J.C.; Bongarzone, E.R.; Feinstein, D.L. P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J. Neuroinflammation, 2008, 5, 33.
162. Labrousse, V.F.; Costes, L.; Aubert, A.; Darnaudéry, M.; Ferreira, G.; Amédée, T.; Layé, S. Impaired interleukin-1beta and c-Fos expression in the hippocampus is associated with a spatial memory deficit in P2X(7) receptor-deficient mice. PLoS ONE, 2009, 4(6), e6006.
163. Bianco, F.; Ceruti, S.; Colombo, A.; Fumagalli, M.; Ferrari, D.; Pizzirani, C.; Matteoli, M.; Di Virgilio, F.; Abbracchio, M.P.; Verderio, C. A role for P2X7 in microglial proliferation. J. Neurochem., 2006, 99(3), 745-758.
164. Chu, Y.X.; Zhang, Y.; Zhang, Y.Q.; Zhao, Z.Q. Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses. Brain Behav. Immun., 2010, 24(7), 1176-1178.
165. Adinolfi, E.; Melchiorri, L.; Falzoni, S.; Chiozzi, P.; Morelli, A.; Tieghi, A.; Cuneo, A.; Castoldi, G.; Di Virgilio, F.; Baricordi, O.R. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood, 2002, 99(2), 706-708.
166. Hillman, K.A.; Woolf, A.S.; Johnson, T.M.; Wade, A.; Unwin, R.J.; Winyard, P.J. The P2X7 ATP receptor modulates renal cyst development in vitro. Biochem. Biophys. Res. Commun., 2004, 322(2), 434-439.
167. Vonend, O.; Turner, C.M.; Chan, C.M.; Loesch, A.; Dell'Anna, G.C.; Srai, K.S.; Burnstock, G.; Unwin, R.J. Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models. Kidney Int., 2004, 66(1), 157-166.
168. Parvathenani, L.K.; Tertyshnikova, S.; Greco, C.R.; Roberts, S.B.; Robertson, B.; Posmantur, R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem., 2003, 278(15), 13309-13317.
169. Franke, H.; Klimke, K.; Brinckmann, U.; Grosche, J.; Francke, M.; Sperlagh, B.; Reichenbach, A.; Liebert, U.G.; Illes, P. P2X(7) receptor-mRNA and-protein in the mouse retina; changes during retinal degeneration in BALBC rds mice. Neurochem. Int., 2005, 47(4), 235-242.
170. Burnstock, G. Purinergic signalling and disorders of the central nervous system. Nat. Rev. Drug Discov., 2008, 7, 575-590.
171. Gao, X.F.; Wang, W.; Yu, Q.; Burnstock, G.; Xiang, Z.H.; He, C. Astroglial P2X7 receptor current density increased following longterm exposure to rotenone. Purinergic Signal., 2011, 7, 65-72.
172. Díaz-Hernández, M.; Díez-Zaera, M.; Sánchez-Nogueiro, J.; Gómez-Villafuertes, R.; Canals, J.M.; Alberch, J.; Miras-Portugal, M.T.; Lucas, J.J. Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration. FASEB J., 2009, 23(6), 1893-1906.
173. Thompson, R.J.; Jackson, M.F.; Olah, M.E.; Rungta, R.L.; Hines, D.J.; Beazely, M.A.; MacDonald, J.F.; MacVicar, B.A. Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus. Science, 2008, 322(5907), 1555-1559.
174. Kim, J.E.; Kang, T.C. The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice. J. Clin. Invest., 2011, 121, 2037-2047.
175. Burnstock, G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev., 2007, 87, 659-797.
176. Engel, T.; Gomez-Villafuertes, R.; Tanaka, K.; Mesuret, G.; Sanz-Rodriguez, A.; Garcia-Huerta, P.; Miras-Portugal, M.T.; Henshall, D.C.; Diaz-Hernandez, M. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice. FASEB J., 2012, 26(4), 1616-1628.
177. Soronen, P.; Mantere, O.; Melartin, T.; Suominen, K.; Vuorilehto, M.; Rytsälä, H.; Arvilommi, P.; Holma, I.; Holma, M.; Jylhä, P.; Valtonen, H.M.; Haukka, J.; Isometsä, E.; Paunio, T. P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts. Am. J. Med. Genet. B Neuropsychiatr. Genet., 2011, 156B, 435-447.
178. Backlund, L.; Nikamo, P.; Hukic, D.S.; Ek, I.R.; Träskman-Bendz, L.; Landén, M.; Edman, G.; Schalling, M.; Frisén, L.; Osby, U. Cognitive manic symptoms associated with the P2RX7 gene in bipolar disorder. Bipolar Disord., 2011, 13(5-6), 500-508.
179. Hejjas, K.; Szekely, A.; Domotor, E.; Halmai, Z.; Balogh, G.; Schilling, B.; Sarosi, A.; Faludi, G.; Sasvari-Szekely, M.; Nemoda, Z. Association between depression and the Gln460Arg polymorphism of P2RX7 gene: a dimensional approach. Am. J. Med. Genet. B Neuropsychiatr. Genet., 2009, 150B, 295-299.
180. Burnstock, G.; Krügel, U.; Abbracchio, M.P.; Illes, P. Purinergic signalling: from normal behaviour to pathological brain function. Prog. Neurobiol., 2011, 95, 229-274.
181. Boucher, A.A.; Arnold, J.C.; Hunt, G.E.; Spiro, A.; Spencer, J.; Brown, C.; McGregor, I.S.; Bennett, M.R.; Kassiou, M. Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test. Neuroscience, 2011, 189, 170-177.
182. Grigoroiu-Serbanescu, M.; Herms, S.; Mühleisen, T.W.; Georgi, A.; Diaconu, C.C.; Strohmaier, J.; Czerski, P.; Hauser, J.; Leszczynska-Rodziewicz, A.; Jamra, R.A.; Babadjanova, G.; Tiganov, A.; Krasnov, V.; Kapiletti, S.; Neagu, A.I.; Vollmer, J.; Breuer, R., Rietschel, M.; Nöthen, M.M.; Cichon, S.; Propping, P.; Nöthen, M.M.; Cichon, S. Variation in P2RX7 candidate gene(rs2230912) is not associated with bipolar I disorder and unipolar major depression in four European samples. Am. J. Med. Genet. B Neuropsychiatr. Genet., 2009, 150B, 1017-1021.
183. Viikki, M.; Kampman, O.; Anttila, S.; Illi, A.; Setälä-Soikkeli, E.; Huuhka, M.; Mononen, N.; Lehtimäki, T.; Leinonen, E. P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT. Neurosci. Lett., 2011, 493, 127-130.
184. Cozzolino, M.; Pesaresi, M.G.; Gerbino, V.; Grosskreutz, J.; Carrì, M.T. Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention. Antioxid. Redox Signal., 2012.
185. Gurney, M.E. Transgenic animal models of familial amyotrophic lateral sclerosis. J. Neurol., 1997, 244(Suppl 2), S15-S20.
186. Boillée, S.; Yamanaka, K., Lobsiger, C.S.; Copeland, N.G.; Jenkins, N.A.; Kassiotis, G.; Kollias, G.; Cleveland, D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science, 2006, 312, 1389-1392.
187. Gandelman, M.; Peluffo, H.; Beckman, J.S.; Cassina, P.; Barbeito, L. Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis. J. Neuroinflammation, 2010, 7, 33.
188. Nylander, A.; Hafler, D.A. Multiple sclerosis. J. Clin. Invest., 2012, 122(4), 1180-1188.
189. Matute, C.; Torre, I.; Pérez-Cerdá, F.; Pérez-Samartín, A.; Alberdi, E.; Etxebarria, E.; Arranz, A.M.; Ravid, R.; Rodríguez-Antigüedad, A.; Sánchez-Gómez, M.; Domercq, M. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J. Neurosci., 2007, 27(35), 9525-9533.
190. Caragnano, M.; Tortorella, P.; Bergami, A.; Ruggieri, M.; Livrea, P.; Specchio, L.M.; Martino, G.; Trojano, M.; Furlan, R.; Avolio, C. Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis. J. Neuroimmunol., 2012.
191. Sun, S.H. Roles of P2X7 receptor in glial and neuroblastoma cells: the therapeutic potential of P2X7 receptor antagonists. Mol. Neurobiol., 2010, 41, 351-355.
192. McLarnon, J.G.; Ryu, J.K.; Walker, D.G.; Choi, H.B. Upregulated expression of purinergic P2X7 receptor in Alzheimer disease and amyloid-α peptide-treated microglia and in peptide-injected rat hippocampus. J. Neuropathol. Exp. Neurol., 2006, 65, 1090-1097.
193. Lee, H.G.; Won, S.M.; Gwag, B.J.; Lee, Y.B. Microglial P2X7 receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease. Exp. Mol. Med., 2011, 43, 7-14.
194. Yanagisawa, D.; Kitamura, Y.; Takata, K.; Hide, I.; Nakata, Y.; Taniguchi, T. Possible involvement of P2X7 receptor activation in microglial neuroprotection against focal cerebral ischemia in rats. Biol. Pharm. Bull., 2008, 31, 1121-1130.
195. Arbeloa, J.; Pérez-Samartín, A.; Gottlieb, M.; Matute, C. P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia. Neurobiol. Dis., 2012, 45, 954-961.
196. Le Feuvre, R.A.; Brough, D.; Touzani, O.; Rothwell, N.J. Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo. J. Cereb. Blood Flow Metab., 2003, 23, 381-384.
197. Fukuhara, N.; Imai, Y.; Sakakibara, A.; Morita, K.; Kitayama, S.; Tanne, K.; Dohi, T. Regulation of the development of allodynia by intrathecally administered P2 purinoceptor agonists and antagonists in mice. Neurosci. Lett., 2000, 292, 25-28.
198. Tsuda, M.; Shigemoto-Mogami, Y.; Koizumi, S.; Mizokoshi, A.; Kohsaka, S.; Salter, M.W.; Inoue, K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature, 2003, 424, 778-783.
199. Jarvis, M.F. The neural-glial purinergic receptor ensemble in chronic pain states. Trends Neurosci., 2010, 33, 48-57.
200. Smith, H.S. Activated microglia in nociception. Pain Physician, 2010, 13, 295-304.
201. Tsuda, M.; Tozaki-Saitoh, H.; Inoue, K. Pain and purinergic signaling. Brain Res. Rev., 2010, 63, 222-232.
202. Honore, P.; Donnelly-Roberts, D.; Namovic, M.T.; Hsieh, G.; Zhu, C.Z.; Mikusa, J.P.; Hernandez, G.; Zhong, C.; Gauvin, D.M.; Chandran, P.; Harris, R.; Medrano, A.P.; Carroll, W.; Marsh, K.; Sullivan, J.P.; Faltynek, C.R.; Jarvis, M.F. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2, 2-dimethylpropyl)-2-(3, 4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J. Pharmacol. Exp. Ther., 2006, 319, 1376-1385.
203. Nelson, D.W.; Gregg, R.J.; Kort, M.E.; Perez-Medrano, A.; Voight, E.A.; Wang, Y.; Grayson, G.; Namovic, M.T.; Donnelly-Roberts, D.L.; Niforatos, W.; Honore, P.; Jarvis, M.F.; Faltynek, C.R.; Carroll, W.A. Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists. J. Med. Chem., 2006, 49, 3659-3666.
204. He, W.J.; Cui, J.; Du, L.; Zhao, Y.D.; Burnstock, G.; Zhou, H.D.; Ruan, H.Z. Spinal P2X7 receptor mediates microglia activationinduced neuropathic pain in the sciatic nerve injury rat model. Behav. Brain Res., 2012, 226, 163-170.
205. Perez-Medrano, A.; Donnelly-Roberts, D.L.; Honore, P.; Hsieh, G.C.; Namovic, M.T.; Peddi, S.; Shuai, Q.; Wang, Y.; Faltynek, C.R.; Jarvis, M.F.; Carroll, W.A. Discovery and biological evaluation of novel cyanoguanidine P2X7 antagonists with analgesic activity in a rat model of neuropathic pain. J. Med. Chem., 2009, 52, 3366-3376.
206. Clark, A.K.; Staniland, A.A.; Marchand, F.; Kaan, T.K.; McMahon, S.B.; Malcangio, M. P2X7-dependent release of interleukin-1b and nociception in the spinal cord following lipopolysaccharide. J. Neurosci., 2010, 30, 573-582.
207. Chessell, I.P.; Hatcher, J.P.; Hughes, J.P.; Ulmann, L.; Green, P.; Mander, P.K.; Reeve, A.J.; Rassendren, F. The role of P2X7 and P2X4 in pain processing; common or divergent pathways? Purinergic Signal., 2006, 2, 46-47.
208. Leung, L.; Cahill, C.M. TNF-a and neuropathic pain-a review. J. Neuroinflammation, 2010, 7, 27.
209. Teixeira, J.M.; Oliveira, M.C.; Parada, C.A.; Tambeli, C.H. Peripheral mechanisms underlying the essential role of P2X7 receptors in the development of inflammatory hyperalgesia. Eur. J. Pharmacol., 2010, 644, 55-60.
210. Sorge, R.E.; Trang, T.; Dorfman, R.; Smith, S.B.; Beggs, S.; Ritchie, J.; Austin, J.S.; Zaykin, D.V.; Meulen, H.V.; Costigan, M.; Herbert, T.A.; Yarkoni-Abitbul, M.; Tichauer, D.; Livneh, J.; Gershon, E.; Zheng, M.; Tan, K.; John, S.L.; Slade, G.D.; Jordan, J.; Woolf, C.J.; Peltz, G.; Maixner, W.; Diatchenko, L.; Seltzer, Z.; Salter, M.W.; Mogil, J.S. Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat. Med., 2012, 18(4), 595-599.
211. Ali, Z.; Laurijssens, B.; Ostenfeld, T.; McHugh, S.; Stylianou, A.; Scott-Stevens, P.; Hosking, L.; Dewit, O.; Richardson, J. C.; Chen, C. Pharmacokinetic and pharmacodynamic profiling of P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects. Br. J. Clin. Pharmacol., 2012.
212. Keystone, E.C.; Wang, M.M.; Layton, M.; Hollis, S.; McInnes, I.B.; on behalf of the D1520C00001 Study Team. Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine. Ann. Rheum. Dis., 2011, [Epub ahead of print].
213. Stock, T.C.; Bloom, B.J.; Wei, N.; Ishaq, S.; Park, W.; Wang, X.; Gupta, P.; Mebus, C.A. Efficacy and safety of CE-224, 535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate. J. Rheumatol., 2012, 39(4), 720-727.